Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Synthesis and vaccine evaluation of the tumor-associated carbohydrate antigen RM2 from prostate cancer.

Journal of the American Chemical Society - 31 Jul 2013

Chuang Hong-Yang, Ren Chien-Tai, Chao Chung-An, Wu Chung-Yi, Shivatare Sachin S, Cheng Ting-Jen R, Wu Chung-Yi, Wong Chi-Huey

Abstract excerpt

We have successfully developed a [1+2+3] one-pot strategy to synthesize the RM2 antigen hexasaccharide that was proposed to be a prostate tumor antigen. The structure of the synthetic product was verified by NMR analysis and antibody binding assay using a glycan microarray. In addition, the synth...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Antigens, Tumor-Associated, Carbohydrate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer Vaccines

Share to Diphtheria Toxin

Share to Galactose

Share to Glycolipids

Share to Oligosaccharides

Share to Vaccines, Synthetic

Source

Identifiers

PMID: 23819648
DOI: 10.1021/ja403609x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23819648-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Synthesis and vaccine evaluation of the tumor-associated carbohydrate antigen RM2 from prostate cancer.PMID 23819648Read ↗

Synthesis, conformational analysis and in vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp 2 -iminosugar fragmentSemantic proximity Read ↗

Recent Advances in the Synthesis of Glycoconjugates for Vaccine DevelopmentSemantic proximity Read ↗

Synthesis, Liposomal Formulation, and Immunological Evaluation of a Minimalistic Carbohydrate-α-GalCer Vaccine Candidate.Semantic proximity Read ↗

Efficient Preparation and Bioactivity Evaluation of Glycan-Defined Glycoproteins.Semantic proximity Read ↗

Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccinesSemantic proximity Read ↗

Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients.Semantic proximity Read ↗

An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.Semantic proximity Read ↗

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.